Monza, Italy

Desiderio Desideri

This inventor holds 1 USPTO granted patent. Top assignee: Rottapharm Spa. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Desiderio Desideri. Retrieved from https://idiyas.com/inventor/desiderio-desideri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Desiderio Desideri: Innovator in Pharmaceutical Chemistry

Introduction

Desiderio Desideri is a notable inventor based in Monza, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quinolinone compounds. His expertise and dedication to research have led to the development of valuable patents that enhance the pharmaceutical landscape.

Latest Patents

Desiderio holds a patent for 7-(4-amino-piperazinyl)- or 7-(4-chloro-piperazinyl)quinolinone. This patent includes compounds of formula I, wherein X is N or >C--F. This invention showcases his ability to create compounds that may have important applications in medicine.

Career Highlights

Desiderio is associated with Rottapharm Spa, a company known for its commitment to pharmaceutical innovation. His work at Rottapharm Spa has allowed him to explore new avenues in drug development and contribute to the advancement of healthcare solutions.

Collaborations

Throughout his career, Desiderio has collaborated with esteemed colleagues such as Riccardo Stradi and Alberto Milanese. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Desiderio Desideri's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field positively, paving the way for future innovations in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…